{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:18:05Z","timestamp":1774005485603,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1995,10]]},"DOI":"10.1212\/wnl.45.10.1914","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:13:21Z","timestamp":1336914801000},"page":"1914-1918","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy"],"prefix":"10.1212","volume":"45","author":[{"given":"Naoyuki","family":"Tsukada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"4","volume":"1","year":"1989","unstructured":"James PB. Multiple sclerosis or blood-brain barrier disease [letter]. Lancet 1989;1:46.","journal-title":"Lancet"},{"key":"e_1_3_1_3_2","first-page":"2","volume":"92","year":"1989","unstructured":"Adams CWM, Poston RN, Buk SJ. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 1989;92:291-306.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/113.1.1"},{"key":"e_1_3_1_5_2","first-page":"2","volume":"9","year":"1986","unstructured":"Wekerle H, Linington C, Lassmann H, Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci 1986;9:271-277.","journal-title":"Trends Neurosci"},{"key":"e_1_3_1_6_2","first-page":"2","volume":"239","year":"1988","unstructured":"Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239:290-292.","journal-title":"Science"},{"key":"e_1_3_1_7_2","first-page":"4","volume":"325","year":"1991","unstructured":"Sharief MK, Phil M, Hentges R. Association between tumor necrosis factor- alpha and disease progression in patients with multiple sclerosis. N Engl J Med 1991;325:467-472.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_8_2","first-page":"2","volume":"102","year":"1991","unstructured":"Tsukada N, Miyagi K, Matsuda M, Yanagisawa N. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J Neurol Sci 1991;102:230-234.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_9_2","first-page":"4","volume":"2","year":"1985","unstructured":"Gassain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-410.","journal-title":"Lancet"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410210102"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"43","year":"1993","unstructured":"Hartung H-P, Michels M, Reiners K, Seeldrayers P, Archelos JJ, Toyka KV. Soluble ICAM-1 serum levels in multiple sclerosis and virus encephalitis. Neurology 1993;43:2331-2335.","journal-title":"Neurology"},{"key":"e_1_3_1_12_2","first-page":"6","volume":"33","year":"1993","unstructured":"Tsukada N, Miyagi K, Matsuda M, Yanagisawa N. Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T lymphotropic virus type 1-associated myelopathy. Ann Neurol 1993;33:646-649.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(93)90068-A"},{"key":"e_1_3_1_14_2","first-page":"1","volume":"136","year":"1990","unstructured":"Sobel RA, Mitchell ME, Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 1990;136:1309-1316.","journal-title":"Am J Pathol"},{"key":"e_1_3_1_15_2","first-page":"8","volume":"35","year":"1994","unstructured":"Washington R, Burton J, Todd RF III, Newman W, Dragovic L, Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol 1994;35:89-97.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_16_2","first-page":"9","volume":"84","year":"1987","unstructured":"Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelialleukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;84:9238-9242.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_17_2","first-page":"3","volume":"667","year":"1992","unstructured":"Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 1992;667:324-331.","journal-title":"Ann NY Acad Sci"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410130103"},{"key":"e_1_3_1_19_2","first-page":"5","volume":"122","year":"1965","unstructured":"Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis--report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965;122:552-570.","journal-title":"Ann NY Acad Sci"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.113.1.1"},{"key":"e_1_3_1_21_2","first-page":"4","volume":"30","year":"1990","unstructured":"Wilcox CE, Ward AMV, Evans A, Baker D, Rothlein R, Turk JL. Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol 1990;30:43-51.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_22_2","first-page":"6","volume":"356","year":"1992","unstructured":"Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha4 beta1 integrin. Nature 1992;356:63-66.","journal-title":"Nature"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410340102"},{"key":"e_1_3_1_24_2","first-page":"1","volume":"145","year":"1994","unstructured":"Steffen BJ, Butcher EC, Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL\/J mouse. Am J Pathol 1994;145:189-201.","journal-title":"Am J Pathol"},{"key":"e_1_3_1_25_2","first-page":"7","volume":"349","year":"1991","unstructured":"Shimizu Y, Shaw S, Graber N, et al. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature 1991;349:799-802.","journal-title":"Nature"},{"key":"e_1_3_1_26_2","first-page":"4","volume":"63","year":"1990","unstructured":"Lowe JB, Stoolman LM, Nair RP, Larsen RD, Berhend TL, Marks RM. ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyl-transferase cDNA. Cell 1990;63:475-484.","journal-title":"Cell"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90279-N"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.250.4980.1"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.1.1"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.1.6"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90174-0"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.45.10.1914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:31:34Z","timestamp":1711549894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.45.10.1914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["10.1212\/WNL.45.10.1914"],"URL":"https:\/\/doi.org\/10.1212\/wnl.45.10.1914","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]}}}